BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6711644)

  • 1. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity.
    Weenink GH; Treffers PE; Vijn P; Smorenberg-Schoorl ME; Ten Cate JW
    Am J Obstet Gynecol; 1984 Apr; 148(8):1092-7. PubMed ID: 6711644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma antithrombin III levels in pre-eclampsia.
    Weenink GH; Treffers PE; Vijn P; Smorenberg-Schoorl ME; ten Cate JW
    Clin Exp Hypertens B; 1983; 2(1):145-62. PubMed ID: 6872275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III levels in preeclampsia.
    Aghai E; Brunstein J; Quitt M; Abramovici H; Froom P
    Isr J Med Sci; 1990 Mar; 26(3):142-3. PubMed ID: 2329037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of reduced antithrombin III activity in women with preeclampsia.
    Weiner CP
    Obstet Gynecol; 1988 Dec; 72(6):847-9. PubMed ID: 3186090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low antithrombin III and high plasma fibronectin in pre-eclampsia.
    Graninger W; Tatra G; Pirich K; Nasr F
    Eur J Obstet Gynecol Reprod Biol; 1985 Apr; 19(4):223-9. PubMed ID: 4007230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III levels in normotensive and hypertensive pregnancy.
    Weenink GH; Borm JJ; Ten Cate JW; Treffers PE
    Gynecol Obstet Invest; 1983; 16(4):230-42. PubMed ID: 6629144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation in pregnancy induced hypertension.
    Weenink GH; ten Cate JW; Treffers PE; Smorenberg-Schoorl ME
    Scand J Clin Lab Invest Suppl; 1985; 178():99-105. PubMed ID: 3867126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III and preeclampsia.
    Brenner B
    Isr J Med Sci; 1990 Mar; 26(3):121-2. PubMed ID: 2329033
    [No Abstract]   [Full Text] [Related]  

  • 10. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia.
    He S; Bremme K; Blombäck M
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):232-8. PubMed ID: 9199820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable maternal and fetal effects of danshensu in an experimental mice model of preeclampsia.
    Shen Y; Hu Y; Zhang Y
    Hypertens Pregnancy; 2011; 30(4):465-80. PubMed ID: 20964615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma antithrombin III activity: an aid in the diagnosis of preeclampsia-eclampsia.
    Weiner CP; Brandt J
    Am J Obstet Gynecol; 1982 Feb; 142(3):275-81. PubMed ID: 7065016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced thrombin generation in normal and hypertensive pregnancy.
    de Boer K; ten Cate JW; Sturk A; Borm JJ; Treffers PE
    Am J Obstet Gynecol; 1989 Jan; 160(1):95-100. PubMed ID: 2521425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma antithrombin III levels in pre-eclampsia and chronic hypertension.
    Leiberman JR; Hagay ZJ; Mazor M; Wiznitzer A; Aharon M; Nathan I; Dvilansky A
    Int J Gynaecol Obstet; 1988 Aug; 27(1):21-4. PubMed ID: 2905294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin cofactor activity and antithrombin III antigen levels in preeclampsia.
    Friedman KD; Borok Z; Owen J
    Thromb Res; 1986 Aug; 43(4):409-16. PubMed ID: 3764801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia.
    Shinyama H; Akira T; Uchida T; Hirahara K; Watanabe M; Kagitani Y
    J Cardiovasc Pharmacol; 1996 May; 27(5):702-11. PubMed ID: 8859941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
    Kobayashi T; Terao T
    Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preeclampsia is not associated with excess fetal clotting.
    Weiner C; Keller S
    Obstet Gynecol; 1986 Dec; 68(6):871-2. PubMed ID: 3785801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III levels in pregnancy induced hypertension.
    Ramalakshmi BA; Raju LA; Raman L
    Natl Med J India; 1995; 8(2):61-2. PubMed ID: 7735061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia.
    Chaiworapongsa T; Yoshimatsu J; Espinoza J; Kim YM; Berman S; Edwin S; Yoon BH; Romero R
    J Matern Fetal Neonatal Med; 2002 Jun; 11(6):362-7. PubMed ID: 12389649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.